Skip to main content
7 Nutrients Affected · Based on CTD Molecular Database

What Does Dexamethasone Deplete? 7 Nutrients Affected

Dexamethasone (Decadron) depletes calcium, vitamin D, potassium, magnesium, zinc, vitamin C, and chromium through glucocorticoid receptor activation that disrupts mineral absorption, increases renal excretion, and alters glucose metabolism. The Comparative Toxicogenomics Database catalogs 11,540 gene interactions for dexamethasone — the largest molecular footprint of any medication in Kelda's database — with 21,866 disease associations across approximately 8 million U.S. prescriptions annually.

Taking this medication? Check what it depletesFree, 10 seconds →

Data sourced from CTD, ChEMBL, FAERS, PubMed, PharmGKB. How we verify this data →
Sources verified as of April 2026
[01]

Depletions Overview

Calcium

High

Dexamethasone reduces intestinal calcium absorption by antagonizing vitamin D-dependent transport proteins, while simultaneously increasing renal calcium excretion through direct effects on kidney tubular handling. According to CTD data linking dexamethasone to 404 curated disease associations including osteonecrosis, the calcium depletion pathway operates through both reduced intake and increased output, making bone density loss one of the most significant consequences of corticosteroid use.

Onset: Weeks of regular use
Bone pain that develops or worsens during treatmentIncreased risk of fractures from minor impacts or fallsMuscle cramps especially in the legs at nightDental sensitivity or weakening tooth enamelNumbness or tingling around the mouth

Vitamin D

High

Dexamethasone accelerates vitamin D metabolism through CYP enzyme induction and reduces vitamin D receptor sensitivity in target tissues. According to 11,540 gene interactions cataloged in CTD for dexamethasone, the glucocorticoid receptor activation affects virtually every vitamin D-dependent pathway. This creates a compounding effect with calcium depletion because vitamin D is required for intestinal calcium absorption, meaning both nutrients decline simultaneously through interconnected mechanisms.

Onset: Weeks of regular use
Bone aches and deep muscle weaknessGetting infections more frequently during treatmentMood worsening or depression developing on the medicationFatigue beyond what the underlying condition explainsSlow wound healing

Potassium

Moderate-High

Dexamethasone's mineralocorticoid activity promotes sodium retention and potassium excretion through the kidney's collecting duct, activating ENaC channels and potassium secretion. According to ChEMBL mechanism-of-action data classifying dexamethasone as a glucocorticoid receptor agonist, this mineralocorticoid cross-reactivity is a class effect that becomes clinically significant with higher doses and longer courses. Dexamethasone has less mineralocorticoid activity than prednisone but still causes meaningful potassium loss.

Onset: Weeks of regular use
Heart palpitations and irregular heartbeatMuscle weakness especially in the legsFatigue that feels heavier than the underlying conditionConstipation developing during treatmentCramping in the calves and feet

Magnesium

Moderate

Dexamethasone increases renal magnesium excretion through mineralocorticoid-mediated effects on tubular handling. Across 26,614 PubMed-indexed articles on dexamethasone, magnesium loss compounds potassium depletion because the kidney cannot retain potassium effectively when magnesium is low. Glucocorticoid-induced stress responses further accelerate magnesium excretion through catecholamine-driven renal wasting.

Onset: Weeks of regular use
Anxiety and irritability layered on top of steroid mood effectsMuscle tension and cramps that don't respond to stretchingDifficulty sleeping beyond the expected steroid insomniaTremor or shakiness in the handsHeart rhythm irregularities

Zinc

Moderate

Dexamethasone increases urinary zinc excretion through glucocorticoid-mediated effects on renal zinc handling. According to PharmGKB annotations linking dexamethasone to ABCB1 and CTLA4 genes affecting drug transport and immune regulation, zinc depletion compounds the immune suppression that is already a primary concern with corticosteroid therapy. Low zinc impairs wound healing in patients who often need it most.

Onset: Months of regular use
Getting infections more easily during and after treatmentSlow wound healing from surgical sites or injuriesLoss of taste or appetite changesHair thinning beyond steroid-related changesSkin becoming thin and fragile

Vitamin C

Moderate

Dexamethasone increases both utilization and urinary excretion of vitamin C. Glucocorticoids generate oxidative stress that consumes antioxidant reserves, while simultaneously accelerating vitamin C clearance through the kidneys. According to CTD data documenting 21,866 disease associations for dexamethasone, the oxidative stress pathway affects tissue repair and immune function. Vitamin C depletion further impairs the wound healing that is already compromised by corticosteroid therapy.

Onset: Weeks of regular use
Bruising more easily than before starting the medicationSlow healing of cuts, bruises, and surgical woundsGums bleeding or becoming sensitiveFatigue and weakness compounding other depletion effectsDry, rough skin developing during treatment

Chromium

Moderate

Dexamethasone increases urinary chromium excretion while simultaneously driving insulin resistance through glucocorticoid receptor activation. Chromium is an essential cofactor for insulin signaling, and its depletion compounds the steroid-induced diabetes that is a major concern with corticosteroid therapy. According to 917 randomized controlled trials involving 868,129 patients in dexamethasone research indexed by CTD, glucose dysregulation is among the most common metabolic side effects.

Onset: Weeks to months of regular use
Blood sugar readings climbing during treatmentIncreased thirst and frequent urinationSugar and carbohydrate cravings intensifyingWeight gain concentrated around the midsection and faceEnergy crashes after meals

Wondering about YOUR specific medications?

Check free — no signup, 10 seconds →
[02]

How It Causes Depletions

Dexamethasone is a synthetic glucocorticoid prescribed to approximately 8 million Americans annually under brand names Decadron and DexPak for severe inflammation, cerebral edema, chemotherapy-induced nausea, severe COVID-19, preterm labor fetal lung maturation, and Cushing's syndrome diagnosis. According to ChEMBL mechanism-of-action data, dexamethasone is a glucocorticoid receptor agonist approximately 25-30 times more potent than cortisol, with Phase 4 indications spanning eye diseases, neoplasms, Crohn's disease, diabetic retinopathy, and laryngeal edema. With oral bioavailability of 74%, 77% protein binding, a plasma half-life of 4 hours but a biological duration of action of 36-54 hours, and a volume of distribution of 51 liters, dexamethasone's potent glucocorticoid activity persists far longer than its plasma presence suggests, meaning nutrient depletion pathways remain active throughout its extended biological half-life.

The Comparative Toxicogenomics Database catalogs 11,540 gene interactions for dexamethasone, with 21,866 total disease associations and 404 curated disease links — the largest molecular footprint of any medication in Kelda's database by a significant margin. This extraordinary gene interaction count reflects dexamethasone's role as a glucocorticoid receptor agonist — the glucocorticoid receptor is a nuclear transcription factor that, when activated, binds to glucocorticoid response elements across thousands of genes throughout the genome. The 7 nutrient depletions flow from this broad transcriptional activation: calcium and vitamin D depletion occur through reduced intestinal absorption and increased renal excretion, potassium and magnesium loss through mineralocorticoid cross-reactivity, zinc through increased urinary excretion, vitamin C through oxidative stress consumption, and chromium through renal wasting compounded by insulin resistance.

PharmGKB pharmacogenomic annotations include 10 entries for dexamethasone, linking genes including ABCB1, CTLA4, CTNNB1, PYGL, and SERPINE1 to drug efficacy and toxicity in conditions including multiple myeloma, acute lymphoblastic leukemia, and osteonecrosis. Across 917 randomized controlled trials involving 868,129 patients in dexamethasone research indexed by CTD, the evidence base spans oncology, immunology, pulmonology, and critical care. Across 212 million rows in Kelda's database, dexamethasone's 7-nutrient depletion profile is the broadest of any single medication, and its 11,540 gene interactions explain why corticosteroid side effects affect virtually every organ system. The calcium-vitamin D-bone density cascade is the most clinically significant, with steroid-induced osteoporosis affecting a substantial proportion of long-term users, but the chromium-insulin-glucose pathway is equally important because steroid-induced diabetes can persist after the medication is discontinued.

[03]

Symptoms to Watch For

Bone pain that develops or worsens during treatmentIncreased risk of fractures from minor impacts or fallsMuscle cramps especially in the legs at nightDental sensitivity or weakening tooth enamelNumbness or tingling around the mouthBone aches and deep muscle weaknessGetting infections more frequently during treatmentMood worsening or depression developing on the medicationFatigue beyond what the underlying condition explainsSlow wound healingHeart palpitations and irregular heartbeatMuscle weakness especially in the legsFatigue that feels heavier than the underlying conditionConstipation developing during treatmentCramping in the calves and feetAnxiety and irritability layered on top of steroid mood effectsMuscle tension and cramps that don't respond to stretchingDifficulty sleeping beyond the expected steroid insomniaTremor or shakiness in the handsHeart rhythm irregularitiesGetting infections more easily during and after treatmentSlow wound healing from surgical sites or injuriesLoss of taste or appetite changesHair thinning beyond steroid-related changesSkin becoming thin and fragileBruising more easily than before starting the medicationSlow healing of cuts, bruises, and surgical woundsGums bleeding or becoming sensitiveFatigue and weakness compounding other depletion effectsDry, rough skin developing during treatmentBlood sugar readings climbing during treatmentIncreased thirst and frequent urinationSugar and carbohydrate cravings intensifyingWeight gain concentrated around the midsection and faceEnergy crashes after meals

Dexamethasone depletes 7 nutrients simultaneously through its broad glucocorticoid receptor activation, which affects gene expression across thousands of pathways. Calcium and vitamin D deplete first within weeks, followed rapidly by potassium, magnesium, and vitamin C. Zinc and chromium deplete more gradually over months. Many of these symptoms overlap with the conditions dexamethasone is prescribed to treat — inflammation-related pain, fatigue, immune suppression — making it difficult to distinguish medication side effects from underlying disease without targeted blood testing.

[04]

What to Monitor

Request these at your next appointment. Check the ones you want to remember.

[05]

What vs Others

NameDepletionsPotencyNotes
DexamethasoneThis drug7 nutrientsVery High25-30x cortisol potency, 11,540 CTD gene interactions, 36-54h biological half-life despite 4h plasma half-life
Prednisone7 nutrientsModerate-HighMost commonly prescribed oral corticosteroid, 4x cortisol potency, more mineralocorticoid activity than dexamethasone
Prednisolone7 nutrientsModerate-HighActive form of prednisone, same depletion profile, preferred in liver impairment where prednisone conversion may be reduced

All corticosteroids deplete the same 7 nutrients through glucocorticoid receptor activation, but potency and mineralocorticoid cross-reactivity vary. Dexamethasone is 25-30x more potent than cortisol with less mineralocorticoid activity than prednisone, meaning slightly less sodium retention and potassium loss per equivalent anti-inflammatory dose. According to CTD data, dexamethasone's 11,540 gene interactions dwarf prednisone's profile, reflecting its higher receptor binding affinity and broader transcriptional effects.

[06]

Food Sources for Depleted Nutrients

FoodAmount per Serving
Sardines with bones351mg per 3.75oz can
Yogurt (plain)296mg per cup
Kale (cooked)177mg per cup
Fortified plant milk300mg per cup
Broccoli (cooked)62mg per cup

Source: USDA Food Composition Database (658,209 food nutrient entries)

[07]

FAQ

[08]

References

  1. [1]Comparative Toxicogenomics Database (CTD): 11,540 dexamethasone gene interactions, 21,866 disease associations, 404 curated disease links (accessed April 2026)
  2. [2]ChEMBL Database: Dexamethasone classified as glucocorticoid receptor agonist, Phase 4 indications for eye diseases, neoplasms, Crohn's disease, diabetic retinopathy, acne, and laryngeal edema (accessed April 2026)
  3. [3]PharmGKB Database: 10 pharmacogenomic annotations for dexamethasone linking ABCB1, CTLA4, CTNNB1, and SERPINE1 to drug efficacy and toxicity (accessed April 2026)
  4. [4]PubMed: 26,614 indexed articles for dexamethasone; 917 randomized controlled trials across 868,129 patients (accessed April 2026)
  5. [5]FAERS Database: Adverse event reporting for dexamethasone including steroid-induced diabetes, osteoporosis, and immunosuppression (accessed April 2026)
  6. [6]Kelda Health Intelligence Platform: Cross-referenced analysis across 212 million rows integrating CTD, ChEMBL, FAERS, PharmGKB, and PubMed datasets (accessed April 2026)
This information is generated from peer-reviewed molecular databases including the Comparative Toxicogenomics Database (CTD), ChEMBL, and indexed PubMed research. It is not medical advice. Always consult your healthcare provider before making changes to your medications or supplements. See our methodology →

Check What YOUR Medications Deplete

Free. No signup. 10 seconds.

Check Now →